OpenAI Delays Launch of Custom GPT Store, Continues Improving AI Assistants

Date:

ChatGPT maker OpenAI has revealed that the launch of its custom GPT store has been delayed until early 2024. An internal memo obtained by Reuters states that the company is taking extra time to refine the GPTs based on customer feedback before introducing them to the market. The initial plan was to release the custom GPTs and store after their announcement at OpenAI’s inaugural developer conference in November. The postponement comes amidst the recent removal and subsequent reinstatement of CEO Sam Altman due to employee threats to resign. OpenAI’s GPTs are designed to act as AI assistants capable of performing real-world tasks like booking flights and can also be shared by users to earn money. The company also aims to collaborate with organizations to create public and private datasets for AI model training, producing more conversational and nuanced training data. OpenAI is actively seeking partners to help develop an open-source dataset for language model training.

See also  Apple Revolutionizes Mac Market with New MacBook Pro and iMac Models, Doubling Market Share, US

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.